Revive Rx LLC dba Revive Rx Pharmacy recalls
FDA enforcement reports naming Revive Rx LLC dba Revive Rx Pharmacy as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 2
- Most recent report
- Jun 5, 2024
- Jun 5, 2024Tirzepatide 10 mg/0Drug · Revive Rx LLC dba Revive Rx PharmacyLabeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionateClass I
- May 31, 2023Tirzepatide 10 mg/0Drug · Revive Rx LLC dba Revive Rx PharmacySub-potent DrugClass II
- Feb 23, 2022HCG 6,000iu (lyo) Human Chorionic Gonadotropin InjDrug · Revive Rx LLC dba Revive Rx PharmacyNon-sterility; bacterial contamination identified as Paenibacillus lautus.Class I